Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.

Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.

Item
http://www.wikidata.org/entity/Q34114732
Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme TreatmentPromising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.Transcranial MRI-Guided Focused Ultrasound: A Review of the Technologic and Neurologic ApplicationsFocused Ultrasound-Induced Blood-Brain Barrier Opening: Association with Mechanical Index and Cavitation Index Analyzed by Dynamic Contrast-Enhanced Magnetic-Resonance ImagingPermeability imaging in pediatric brain tumors.Enhanced Therapeutic Epidermal Growth Factor Receptor (EGFR) Antibody Delivery via Pulsed Ultrasound with Targeting Microbubbles for Glioma TreatmentDrug delivery systems, CNS protection, and the blood brain barrierDynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis.Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening.Plasmonics-enhanced and optically modulated delivery of gold nanostars into brain tumor.Gold nanoparticle imaging and radiotherapy of brain tumors in mice.Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research.Transendothelial Transport and Its Role in Therapeutics.Impacts of blood-brain barrier in drug delivery and targeting of brain tumorsFocused ultrasound-induced blood-brain barrier disruption enhances the delivery of cytarabine to the rat brain.
P2860

Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.

Item
http://www.wikidata.org/entity/Q34114732
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Enhanced therapeutic agent del ...... he current preclinical status.
@ast
Enhanced therapeutic agent del ...... he current preclinical status.
@en
Enhanced therapeutic agent del ...... he current preclinical status.
@nl
type
label
Enhanced therapeutic agent del ...... he current preclinical status.
@ast
Enhanced therapeutic agent del ...... he current preclinical status.
@en
Enhanced therapeutic agent del ...... he current preclinical status.
@nl
prefLabel
Enhanced therapeutic agent del ...... he current preclinical status.
@ast
Enhanced therapeutic agent del ...... he current preclinical status.
@en
Enhanced therapeutic agent del ...... he current preclinical status.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Enhanced therapeutic agent del ...... he current preclinical status.
@en
P2093
P304
P31
P356
10.3171/2011.10.FOCUS11238
P433
P478
P50
P577
P698
P921